Webinars

Our informative webinars are in partnership with the Journal of Parkinson’s Disease and Parkinson’s Movement.

These quarterly webinars are each chaired by Professor Patrick Brundin (Van Andel Research Institute) who is joined by a different panel of experts discussing important topics and related research within the Parkinson's community.

Re-watch the webinars here...

Upcoming Webinar: Exercise and Parkinson's

We will be discussing recent publications around the theme of exercise in Parkinson's. Read more

Webinar - Dyskinesia in Parkinson's

Watch our most recent webinar - 'Dyskinesia in Parkinson's' Read more

Webinar - How Does Parkinson’s Disease Begin? Neuroanatomical Pathways, Prions and Histology.

The panel discuss the paper 'How Does Parkinson’s Disease Begin? Perspectives on Neuroanatomical Pathways, Prions, and Histology' by Professor Per Borghammer Read more

Webinar - Does Exenatide reduce Non-motor Symptoms in Parkinson’s?

Professor Brundin is joined by Professor Tom Foltynie who led the exenatide trial... Read more

Webinar - Sleep and Parkinson’s Disease

Professor Patrik Brundin is joined by a panel of experts discussing ‘Sleep and Parkinson’s Disease’. Read more

Webinar - Targeting the Genetics of Parkinson's

Professor Patrik Brundin leads a panel discussing the genetics of Parkinson's... Read more

Webinar - Stem Cell (Cell Replacement) Therapy

This webinar focuses on developments in the field of stem cell therapy for Parkinson's... Read more

Latest

Upcoming Webinar: Exercise and Parkinson's

We will be discussing recent publications around the theme of exercise in Parkinson's.

A Sub-Study Investigating Azathioprine in Parkinson's

In Parkinson’s there appears to be an over-abundance of inflammatory cells in the brain. This study will examine how azathioprine impacts this inflammation to determine whether this drug could be a future treatment for Parkinson's

Simon Cooper from AEGIS London has been awarded the Lloyd’s Market Charity Award

Simon Cooper from AEGIS London has been awarded the Lloyd’s Market Charity Award in recognition of his incredible work raising funds and awareness for The Cure Parkinson’s Trust.

The 2020 Ricky Road Run

Take part in the 2020 Ricky Road Run to conquer the 10 mile hilly route through Rickmansworth and Chorleywood, Hertfordshire in support of CPT.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.

Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.

New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...

Science news

Read the latest Parkinson's science and research news here.

Trials - Repurposed Drugs

Our international Linked Clinical Trials initiative (LCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.

Apply for Funding

The NAC Trial - the facts

Our story

Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.